Endometrial Cancer Prevention, Early Diagnosis and Treatment: Advances and Challenges

Dear Colleagues,

The rising global incidence of endometrial cancer means that more women than ever are living with and, unfortunately, also dying from this disease. Whilst surgery in combination with radio- and chemotherapy has long been the cornerstone of endometrial cancer treatment, increasing knowledge of endometrial cancer biology has ensured the success of fertility-sparing approaches and enabled the personalisation of care. The molecular characterisation of tumours and clinical trials of immunotherapies are set to revolutionise how we manage the disease as we move towards improving disease control whilst minimising the side effects of treatment. 

This Special Issue aims to highlight recent advances in the prevention, early diagnosis, and treatment of early and advanced/recurrent endometrial cancer and to answer any outstanding research questions. Both original research articles and review papers are welcome to be submitted to this Special Issue. 

Dr. Sarah J. Kitson
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• endometrial cancer
• gynaecologic oncology
• surgery
• prevention
• early diagnosis
• advanced therapy
• molecular classification
• biomarkers